Cargando…
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different
No longer is histology solely predictive of cancer treatment and outcome. There is an increasing influence of tumor genomic characteristics on therapeutic options. Both breast and ovarian cancers are at higher risk of development in patients with BRCA 1/2-germline mutations. Recent data from The Can...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936197/ https://www.ncbi.nlm.nih.gov/pubmed/24579064 http://dx.doi.org/10.3389/fonc.2014.00019 |